Dosage form design considerations. (Record no. 41948)

MARC details
000 -LEADER
fixed length control field pam a22 i 4500
001 - CONTROL NUMBER
control field AALScienceDirectebook000003
003 - CONTROL NUMBER IDENTIFIER
control field BD-DhAAL
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20191205133250.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu|||unuuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 180730s2018 enk ob 001 0 eng d
015 ## - NATIONAL BIBLIOGRAPHY NUMBER
National bibliography number GBB8C0857
Source bnb
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 018922633
Source Uk
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0128144246
International Standard Book Number 9780128144244
Cancelled/invalid ISBN 0128144238
Cancelled/invalid ISBN 9780128144237
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1046633728
Canceled/invalid control number (OCoLC)1047806807
040 ## - CATALOGING SOURCE
Original cataloging agency BD-DhAAL
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS200
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.19
Edition number 23
245 00 - TITLE STATEMENT
Title Dosage form design considerations.
Number of part/section of a work Volume 1 /
Statement of responsibility, etc edited by Rakesh K. Tekade.
Medium [electronic resource]
260 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc London, United Kingdom :
Name of publisher, distributor, etc Elsevier,
Date of publication, distribution, etc [2018]
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource.
490 1# - SERIES STATEMENT
Series statement Advances in pharmaceutical product development and research series
500 ## - GENERAL NOTE
General note <strong>Off-Campus Access:</strong> Athens ID and Password Required
General note <strong>On-Campus Access:</strong> No User ID or Password Required
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Front Cover; Dosage Form Design Considerations; Copyright Page; Dedication; Contents; List of Contributors; About the Editor; 1 Preformulation in Drug Research and Pharmaceutical Product Development; 1.1 Introduction; 1.1.1 An Overview of Formulation Life Cycle and Management; 1.1.2 Need of Preformulation: First Stage of Formulation Development; 1.1.3 Major Hurdles Impeding Successful Product Development; 1.1.4 Role of Preformulation During Product Development; 1.2 Parameters of preformulation studies; 1.2.1 Solubility; 1.2.2 The Permeability of the Drug
Formatted contents note 1.2.3 Bulk Characterization: Physical, Analytical, and Physicochemical1.2.4 Inherent Properties: pH, pKa, Log P, Log D, and Intrinsic Dissolution; 1.2.5 Stability: The Solution, Solid State, & ICH Photostability; 1.2.6 Drug-Excipient Compatibility; 1.2.7 Particle Size and Distribution; 1.2.8 Thermal Properties; 1.2.9 Hygroscopicity; 1.2.10 Bulk Properties; 1.2.11 Mechanical Properties and Compatibility; 1.2.12 Crystallinity and Polymorphism; 1.3 Role of preformulation in drug discovery; 1.3.1 Material Properties in Lead Selection, High Throughput Preformulation Studies
Formatted contents note 1.3.2 "Drugability" of New Chemical Entities1.3.3 Tools to Assist in Lead Selection; 1.4 Role of preformulation in drug development; 1.4.1 Identification of Challenges During Formulation Development: Pre-Assumptions; 1.4.2 The Dosage Form Specific Studies; 1.5 Preformulation studies of proteins and peptides; 1.6 Preformulation in vaccine development: Critical views; 1.7 Preformulation studies of packaging components; 1.8 Preformulation in 21st century: technological advancements; 1.8.1 Computerization and Aid of Software in the Preformulation Studies
Formatted contents note 1.8.2 Artificial Neural Network Tool Used in the Factorial Design: An Optimization Approach1.9 Case studies on preformulation of dosage forms; 1.10 Pharmacokinetics and preformulation: Point to note; 1.11 Rules and regulations in preformulation studies: Role of regulatory bodies; 1.12 Future remarks and conclusion; Acknowledgment; Abbreviations; References; Further Reading; 2 Physicochemical Aspects to Be Considered in Pharmaceutical Product Development; 2.1 Introduction; 2.2 Physical Characteristics of Solid Substances Used in Pharmaceutical Product Development
Formatted contents note 2.2.1 Crystalline Solid-State Substances2.2.1.1 Polymorphism; 2.2.1.2 Hydrates; 2.2.1.3 Solvates; 2.2.1.4 Cocrystals; 2.2.2 Amorphous Solids; 2.2.3 Particle Size; 2.2.4 Wettability; 2.2.5 Hygroscopicity; 2.3 Chemical Characteristics to be Considered in Pharmaceutical Product Development; 2.3.1 Degradation Reactions of Drugs; 2.3.1.1 Hydrolysis; 2.3.1.2 Dehydration; 2.3.1.3 Oxidation; 2.3.1.4 Photochemical Degradation; 2.3.1.5 Isomerization; 2.3.1.6 Polymerization; 2.3.1.7 Other Reactions; 2.4 Solubility Aspects in Pharmaceutical Products Development; 2.4.1 Aqueous Solubility
506 ## - RESTRICTIONS ON ACCESS NOTE
Terms governing access Electronic access restricted to authorized BRAC University faculty, staff and students
520 ## - SUMMARY, ETC.
Summary, etc Dosage Form Design Parameters, Volume I, examines the history and current state of the field within the pharmaceutical sciences, presenting key developments. Content includes drug development issues, the scale up of formulations, regulatory issues, intellectual property, solid state properties and polymorphism. Written by experts in the field, this volume in the Advances in Pharmaceutical Product Development and Research series deepens our understanding of dosage form design parameters. Chapters delve into a particular aspect of this fundamental field, covering principles, methodologies and the technologies employed by pharmaceutical scientists. In addition, the book contains a comprehensive examination suitable for researchers and advanced students working in pharmaceuticals, cosmetics, biotechnology and related industries.
538 ## - SYSTEM DETAILS NOTE
System details note Mode of access: Internet
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug delivery systems.
9 (RLIN) 37984
Topical term or geographic name as entry element Drug development.
9 (RLIN) 37985
Topical term or geographic name as entry element Drugs
General subdivision Design.
9 (RLIN) 37986
Topical term or geographic name as entry element Drugs
General subdivision Dosage forms.
9 (RLIN) 37987
Topical term or geographic name as entry element Drug delivery systems.
Source of heading or term fast
9 (RLIN) 37984
Topical term or geographic name as entry element Drug development.
Source of heading or term fast
9 (RLIN) 37985
Topical term or geographic name as entry element Drugs
General subdivision Design.
Source of heading or term fast
9 (RLIN) 37986
Topical term or geographic name as entry element Drugs
General subdivision Dosage forms.
Source of heading or term fast
9 (RLIN) 37987
Topical term or geographic name as entry element MEDICAL / Pharmacology.
Source of heading or term bisacsh
9 (RLIN) 37988
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
-- 37989
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tekade, Rakesh K.,
Relator term editor.
9 (RLIN) 37990
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Qualifying information Original
International Standard Book Number 0128144238
-- 9780128144237
Record control number (OCoLC)1007038271
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Advances in pharmaceutical product development and research series.
9 (RLIN) 37991
856 40 - ELECTRONIC LOCATION AND ACCESS
Public note Full text available on ScienceDirect
Uniform Resource Identifier <a href="https://www.sciencedirect.com/science/book/9780128144237">https://www.sciencedirect.com/science/book/9780128144237</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Item type E-Book
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Total Checkouts Full call number Date last seen Price effective from Koha item type
    Dewey Decimal Classification     Ayesha Abed Library Ayesha Abed Library 05/12/2019   615.19 DOS 05/12/2019 05/12/2019 E-Book